GUERBET (EPA:GBT) | WebDisclosure

Basculer en Français

10443	Companies
219215	Keywords
148675	Articles
115956	Press releases

Home
Companies
GUERBET

BRIEF

published on 05/22/2026 at 18:19, 3 hours 57 minutes ago

Changes within the Guerbet Board of Directors

Board Of Directors Appointment Guerbet Majority Shareholder Antoine Fady
BRIEF

published on 05/22/2026 at 18:19, 3 hours 57 minutes ago

Évolution au sein du Conseil d'administration de Guerbet

Conseil D'administration Nomination Guerbet Actionnaire Majoritaire Antoine Fady
PRESS RELEASE

published on 05/22/2026 at 18:14, 4 hours 2 minutes ago

Guerbet: Changes to the Composition of Guerbet’s Board of Directors.
Guerbet announces changes to its Board of Directors with the appointment of Mr. Antoine Fady as Chairman and three new directors representing the majority shareholder

Board Of Directors Chairman Guerbet Majority Shareholder Antoine Fady
PRESS RELEASE

published on 05/22/2026 at 18:14, 4 hours 2 minutes ago

Guerbet : Evolution de la composition du Conseil d’administration de Guerbet.
Evolution de la composition du Conseil d'administration de Guerbet avec les nominations de Monsieur Antoine Fady en tant qu'administrateur indépendant et Président, ainsi que de trois nouveaux administrateurs représentant l'actionnaire majoritaire

Conseil D'administration Nominations Guerbet Actionnaire Majoritaire Antoine Fady
BRIEF

published on 04/24/2026 at 11:10, 28 days 11 hours ago

Guerbet franchit une étape importante dans l'embolisation vasculaire pour Lipiodol®

Imagerie Médicale Radiologie Interventionnelle Approbation De L'UE Lipiodol® Ultra Fluid Embolisation Vasculaire
BRIEF

published on 04/24/2026 at 11:10, 28 days 11 hours ago

Guerbet Achieves Milestone in Vascular Embolization for Lipiodol®

Medical Imaging EU Approval Interventional Radiology Lipiodol® Ultra Fluid Vascular Embolization
PRESS RELEASE

published on 04/24/2026 at 11:05, 28 days 11 hours ago

Guerbet announces an important milestone achievement in the "Vascular Embolization" indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)
Guerbet achieves regulatory milestone for Lipiodol Ultra Fluid in interventional radiology, enabling enhanced embolization procedures with cyanoacrylate-based surgical glues for vessel occlusion

Guerbet Embolization Interventional Radiology Lipiodol Ultra Fluid Cyanoacrylate-based Glues
BRIEF

published on 03/20/2026 at 15:49, 2 months 2 days ago

Guerbet: Publication of the 2025 Universal Registration Document

Financial Report Guerbet Medical Imaging Financial Markets Registration Document
BRIEF

published on 03/20/2026 at 15:49, 2 months 2 days ago

Guerbet : Publication du Document d'enregistrement universel 2025

Rapport Financier Guerbet Imagerie Médicale Marchés Financiers Document D'enregistrement
PRESS RELEASE

published on 03/20/2026 at 15:44, 2 months 2 days ago

GUERBET : Mise à disposition du Document d’enregistrement universel 2025
Guerbet dépose son Document d’enregistrement universel 2025 à l'AMF. Consultation gratuite en ligne. Prochain RDV : Publication du chiffre d’affaires du 1er trimestre 2026 le 23 avril 2026

Chiffre D’affaires AMF Guerbet Publication Document D’Enregistrement Universel 2025

Accesswire

Published on 05/22/2026 at 18:40, 3 hours 36 minutes ago

Vertical Announces Grant of Options
Published on 05/22/2026 at 14:04, 8 hours 12 minutes ago

Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)
Published on 05/22/2026 at 14:00, 8 hours 16 minutes ago

Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Published on 05/22/2026 at 14:00, 8 hours 16 minutes ago

CCL Industries Inc. Announces Renewal of Normal Course Issuer Bid and Approval of Automatic Securities Purchase Plan
Published on 05/22/2026 at 14:00, 8 hours 16 minutes ago

Dateline Appoints Alvarez & Marsal to Manage Colosseum Development

View all ACCESSWIRE

EQS Group

Published on 05/22/2026 at 22:05, 11 minutes ago

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 11 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 2 hours 25 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 3 hours 43 minutes ago

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 3 hours 46 minutes ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors

Les Echos

Published on 05/22/2026 at 19:35, 2 hours 41 minutes ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 4 hours 11 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 4 hours 11 minutes ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 9 hours 23 minutes ago

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 9 hours 23 minutes ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE